SMART Guidelines L3 SOP
1.1.0 - ci-build International flag

SMART Guidelines L3 SOP, published by WHO. This guide is not an authorized publication; it is the continuous build for version 1.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/WorldHealthOrganization/smart-ig-starter-kit/ and changes regularly. See the Directory of published versions

Validating IG

Validating Smart Guidelines L3 is a responsibility of the author. This comprehends several activities:

  1. Ensure that the content of the L2 is correctly represented by L3 artifacts
  2. Verify that the rules for each created artifact are followed e.g. that there are no issues with the artifacts
  3. Confirm the functionality of L3 artifacts - for example that the StructureMaps extraction gives exactly the expected output, using reference tooling
  4. Address any other dependencies and governance issues e.g. updates to common definitions, etc.

These are described below:

Content coverage

This is a manual effort. The L3 author is expected to ensure that all the expectations on the L2 are covered by some artifact.

Verify conformance with QA rules

The quality checks are increasingly automated. Every Guide contains a QA page (see QA Check) which automatically identifies issues like missing elements, references not found, etc.

Validating L3 artifact functionality

There's a reference set of tools that can be used to validate the functionality of the artifacts, namely StructureMaps and Decision/Scheduling logic and indicators. Each Guide has a Testing page that contains links to enable local testing.

Follow governance process

The results of L3 authoring can be subject to governance processes outside the authoring of a specific L3 guide, e.g. creating common terms or common libraries, addressing issues or requesting changes in dependencies. For these, the L3 author is a contributor to a shared pool of resources, and the governance process will determine how to onboard any such artifacts and issues.